Chembio Diagn (CEMI) Tops Q1 EPS by 4c

May 7, 2015 8:51 AM EDT

Chembio Diagn (NASDAQ: CEMI) reported Q1 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $5.2 million.

For earnings history and earnings-related data on Chembio Diagn (CEMI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings